Latest in: Press Release

CARB-X releases Updated Eligibility Criteria for 2025 Funding Round targeting Global Infectious Disease Threats

Seeking therapeutics for infections caused by Gram-negative pathogens and diagnostics for Salmonella Typhi (BOSTON: November 19, 2025) – Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today updated eligibility criteria to support its second call of the …
November 19, 2025

REACH Asia – Responsive Engagement for Advancing Community and Health Research in Asia

Join us on 8–9 Dec 2025 for the REACH Asia Forum on Community Engagement! Hear from experts and community leaders across the region on strengthening community engagement and participation in health research.Register at 🔗 https://ad-id.co/reach2025
November 17, 2025

‘Framing JUST solutions for ACCESS to treatment against AMR’

Date: 4 November 2025 Venue: British Academy, 10-11 Carlton House Terrace, London SW1Y 5AH, United Kingdom This workshop is designed to: Create a collaborative space for policymakers, researchers, patients, and funders to co-develop fair and practical solutions. …
October 7, 2025

ADVANCE-ID Directors make presentations at the inaugural Global AMR Innovators Conference (GAMRIC), London, October 1 and 2, 2025

ADVANCE-ID Directors, Drs David Paterson and Mo Yin, have made invited presentations at the inaugural GAMRIC meeting held in London. They discussed key AMR issues such as the high mortality burden attributed to multiresistant Gram negative bacilli in …
October 2, 2025

RESISTALKs Podcast Episode: Exploring the BEATLE Trial in Febrile Neutropenia

We are pleased to announce the release of a new episode in the RESISTALKs podcast series. Episode Title: Discussing the BEATLE trial “Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in …
July 7, 2025

Infex agrees collaboration with Asian clinical trials network, ADVANCE-ID

Memorandum of Understanding signed to investigate hospital-acquired drug-resistant infections in Asia Alderley Park, Cheshire, U.K. Infex Therapeutics, a leading anti-infectives specialist, announces that it has signed a memorandum of understanding (MOU) (the “Collaboration”) with ADVANCE-ID, a …
May 21, 2025

2nd ADVANCE-ID Network Symposium (Event Highlights)

It was a remarkable gathering of professionals, researchers, and clinicians dedicated to advancing the fight against antimicrobial resistance (AMR). Held at Grand Copthorne Waterfront Hotel (Singapore) on 18-19 February 2025, this symposium brought together leading experts …
May 2, 2025

Join us as a Research Fellow (Clinical Trial Community Engagement)

We're hiring! Join us as a Research Fellow (Clinical Trial Community Engagement) at ADVANCE-ID! Conduct research on risk communication, public perceptions, attitudes & community engagement in clinical trial settings in Asia. Find out more in the …
April 2, 2025

Applications Now Open – MORU-OUCRU Discovery Research Academy (MODRA)

The applications for the MORU–OUCRU Discovery Research Academy (MODRA) are now open from 3rd March to 25th April 2025. MODRA is a 18-month programme designed to support early- to mid-career postdoctoral researchers in South and Southeast …
March 10, 2025

Save the Date: 2nd ADVANCE-ID Network Symposium

We are excited to announce that the 2nd ADVANCE-ID Network Symposium will be held on 18 to 19 Feb 2025 in Singapore. Under the theme “Translating Clinical Research into Strategies for Targeting AMR Treatment, Detection, and Prevention,” this symposium will …
November 12, 2024
Logo-Lockup

Copyright © ADVANCE-ID. All rights reserved.

ADVANCE-ID
Saw Swee Hock School of Public Health
National University of Singapore

Tahir Foundation Building
National University of Singapore
12 Science Drive 2, #10-01, Singapore 117549
+65 6516 4988